Solein is a versatile ingredient: thanks to its mild taste, products made with Solein can taste like anything Solein Protein ...

AstraZenca is testing a once-daily PCSK9 inhibitor, currently known as AZD0780. After 12 weeks of use alongside standard ...

CEO Stephen Glover said, “ZyVersa is developing Cholesterol Efflux Mediator VAR 200 for treatment of chronic kidney diseases, initially ...

The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, in collaboration with researchers across ...

The findings build on previous work from the research team demonstrating that LMHR individuals have similar levels of coronary plaque to a carefully-matched comparison group with normal LDL levels, ...

The number of people living with dementia, including Alzheimer’s, is expected almost to double every 20 years.

AstraZeneca Plc’s experimental cholesterol drug significantly reduced “bad” cholesterol in a mid-stage trial, boosting hopes ...

Drugs from Novartis, Amgen and now Lilly have proven powerfully effective at reducing Lp(a). Whether that will translate to a ...

In an exclusive interview with NBC News, President Donald Trump said there were methods that would allow him to seek a third ...

An NIH Pediatric Oncology Branch researcher's lab jacket, embroidered with the NIH logo with blue chevron detail. The POB is ...

A single dose of an experimental drug dramatically reduced levels of a deadly form of cholesterol, often thought to be untreatable, for up to one year. Lipoprotein(a) is a type of cholesterol that ...